ABAT and breast carcinoma: Estrogen-receptor positive (ER+) breast cancers express highly upregulated levels of ABAT transcripts and its encoded protein, and have a more favorable patient prognosis, than low-ABAT-expressing hormone-insensitive breast cancers [35].